Johnson & Johnson forecasts $2.5B of coronavirus vaccine sales
Johnson & Johnson said it will sell $2.5 billion worth of its COVID-19 vaccine this year and pushed back against concerns over its effectiveness against the delta variant.
Wednesday, July 21, 2021
Johnson & Johnson forecasts $2.5B of coronavirus vaccine sales
Johnson & Johnson forecasts $2.5B of coronavirus vaccine sales
Johnson & Johnson said it will sell $2.5 billion worth of its COVID-19 vaccine this year and pushed back against concerns over its effectiveness against the delta variant.
0 comments:
Post a Comment